{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:50:21Z","timestamp":1791251421154,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/hjh.0b013e32835b71d6","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T09:19:52Z","timestamp":1355908792000},"page":"404-413","source":"Crossref","is-referenced-by-count":24,"title":["Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension"],"prefix":"10.1097","volume":"31","author":[{"given":"Pieter M.","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wijnanda J.","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert-Jan H.","family":"van den Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile L.E.","family":"de Bruijne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Deinum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel N.","family":"Kerstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce H.A.","family":"Arnoldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend Jan","family":"Woittiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna A.M.","family":"Wijbenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zietse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H. Jan","family":"Danser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton H.","family":"van den Meiracker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210208","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.","volume":"57","author":"de la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"R2-25-20210208","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients.","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"R3-25-20210208","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/HJH.0b013e328014954d","article-title":"Low-dose spironolactone in the management of resistant hypertension: a surveillance study.","volume":"25","author":"Lane","year":"2007","journal-title":"J Hypertens"},{"key":"R4-25-20210208","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension.","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"R5-25-20210208","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0895-7061(01)02342-1","article-title":"The role of spironolactone in the treatment of patients with refractory hypertension.","volume":"15","author":"Ouzan","year":"2002","journal-title":"Am J Hypertens"},{"key":"R6-25-20210208","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension.","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"key":"R7-25-20210208","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.amjhyper.2005.11.016","article-title":"Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension.","volume":"19","author":"Sharabi","year":"2006","journal-title":"Am J Hypertens"},{"key":"R8-25-20210208","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension.","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"R9-25-20210208","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0300-8932(09)70158-7","article-title":"Spironolactone and doxazosin treatment in patients with resistant hypertension.","volume":"62","author":"Rodilla","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"R10-25-20210208","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension.","volume":"55","author":"de Souza","year":"2010","journal-title":"Hypertension"},{"key":"R11-25-20210208","doi-asserted-by":"crossref","first-page":"368140","DOI":"10.4061\/2011\/368140","article-title":"Long-term use of aldosterone-receptor antagonists in uncontrolled hypertension: a retrospective analysis.","volume":"2011","author":"Jansen","year":"2011","journal-title":"Int J Hypertens"},{"key":"R12-25-20210208","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jash.2008.05.005","article-title":"Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension.","volume":"2","author":"Calhoun","year":"2008","journal-title":"J Am Soc Hypertens: JASH"},{"key":"R13-25-20210208","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/HJH.0b013e32833d4c99","article-title":"Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin-angiotensin-aldosterone system.","volume":"28","author":"Alvarez-Alvarez","year":"2010","journal-title":"J Hypertens"},{"key":"R14-25-20210208","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jhh.2011.60","article-title":"Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.","volume":"26","author":"Pisoni","year":"2011","journal-title":"J Hum Hypertens"},{"key":"R15-25-20210208","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jash.2010.10.001","article-title":"The effect of low-dose spironolactone on resistant hypertension.","volume":"4","author":"Engbaek","year":"2010","journal-title":"J Am Soc Hypertens: JASH"},{"key":"R16-25-20210208","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.","volume":"57","author":"Vaclavik","year":"2011","journal-title":"Hypertension"},{"key":"R17-25-20210208","first-page":"1631","article-title":"Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone Am J H","volume":"18","author":"Mahmud","year":"2005","journal-title":"ypertens"},{"key":"R18-25-20210208","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0002-9149(76)90409-4","article-title":"Controlled treatment of primary hypertension with propranolol and spironolactone. A crossover study with special reference to initial plasma renin activity.","volume":"37","author":"Karlberg","year":"1976","journal-title":"Am J Cardiol"},{"key":"R19-25-20210208","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","article-title":"Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.","volume":"93","author":"Williams","year":"2004","journal-title":"Am J Cardiol"},{"key":"R20-25-20210208","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ahj.2004.12.005","article-title":"Effects of eplerenone versus losartan in patients with low-renin hypertension.","volume":"150","author":"Weinberger","year":"2005","journal-title":"Am Heart J"},{"key":"R21-25-20210208","first-page":"1203","article-title":"Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy J Clin P","volume":"43","author":"Prisant","year":"2003","journal-title":"harmacol"},{"key":"R22-25-20210208","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J Nephrol"},{"key":"R23-25-20210208","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension.","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"key":"R24-25-20210208","first-page":"226","article-title":"Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo.","volume":"12","author":"West","year":"1986","journal-title":"Miner Electrolyte Metab"},{"key":"R25-25-20210208","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0272-6386(12)80076-X","article-title":"The transtubular potassium concentration in patients with hypokalemia and hyperkalemia.","volume":"15","author":"Ethier","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"R26-25-20210208","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline.","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-25-20210208","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads.","volume":"37","author":"Sokolow","year":"1949","journal-title":"Am Heart J"},{"key":"R30-25-20210208","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","article-title":"Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.","volume":"91","author":"Staessen","year":"1981","journal-title":"J Endocrinol"},{"key":"R31-25-20210208","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1007\/s00125-004-1542-0","article-title":"Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.","volume":"47","author":"Schjoedt","year":"2004","journal-title":"Diabetologia"},{"key":"R32-25-20210208","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.amjhyper.2006.02.002","article-title":"Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension.","volume":"19","author":"Strauch","year":"2006","journal-title":"Am J Hypertens"},{"key":"R33-25-20210208","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjhyper.2004.08.026","article-title":"Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.","volume":"18","author":"Mahmud","year":"2005","journal-title":"Am J Hypertens"},{"key":"R34-25-20210208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0021-9150(02)00363-5","article-title":"Aldosterone induces contraction of the resistance arteries in man.","volume":"166","author":"Romagni","year":"2003","journal-title":"Atherosclerosis"},{"key":"R35-25-20210208","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ahj.2009.12.035","article-title":"Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).","volume":"159","author":"Jain","year":"2010","journal-title":"Am Heart J"},{"key":"R36-25-20210208","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/HJH.0b013e32832810ed","article-title":"Aldosterone-receptor antagonism in hypertension.","volume":"27","author":"Jansen","year":"2009","journal-title":"J Hypertens"},{"key":"R37-25-20210208","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ahj.2004.10.005","article-title":"Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.","volume":"148","author":"Tamirisa","year":"2004","journal-title":"Am Heart J"},{"key":"R38-25-20210208","doi-asserted-by":"crossref","first-page":"233S","DOI":"10.1093\/ajh\/6.3.9S","article-title":"Ambulatory blood pressure monitoring in the design of studies on antihypertensive drug efficacy.","volume":"6","author":"Mancia","year":"1993","journal-title":"Am J Hypertens"},{"key":"R39-25-20210208","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ahj.2005.02.014","article-title":"Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting.","volume":"151","author":"White","year":"2006","journal-title":"Am Heart J"},{"key":"R40-25-20210208","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R41-25-20210208","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"R42-25-20210208","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.111.180497","article-title":"Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.","volume":"58","author":"Hanselin","year":"2011","journal-title":"Hypertension"},{"key":"R43-25-20210208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1751-7176.2011.00556.x","article-title":"Refractory hypertension: definition, prevalence, and patient characteristics.","volume":"14","author":"Acelajado","year":"2012","journal-title":"J Clin Hypertens"},{"key":"R44-25-20210208","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jash.2011.08.003","article-title":"Validation of a therapeutic scheme for the treatment of resistant hypertension.","volume":"5","author":"Segura","year":"2011","journal-title":"J Am Soc Hypertens: JASH"},{"key":"R45-25-20210208","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"R46-25-20210208","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.109.131235","article-title":"Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.","volume":"54","author":"Pimenta","year":"2009","journal-title":"Hypertension"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e32835b71d6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:39:49Z","timestamp":1621885189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201302000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32835b71d6","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}